Home » Newsletters » BioWorld Science

BioWorld Science

March 23, 2012

View Archived Issues

New product has antidiabetic and antiobesity effects in various animal models

Researchers provide further data on briakinumab efficacy

Addex provides promising topline data from phase IIa trial in levodopa-induced dyskinesia

Gene expression-based MAMPS for the prognosis of breast cancer

Novel naphthoquinones designed in China

Novel GPR119 receptor agonists prepared by Lupin

First-in-human trial of H1N1 influenza vaccine using iBioLaunch technology completed

Taisho presents novel sodium/glucose cotransporter 1 inhibitors

New PUFA metabolites patented by University of Tokyo

Phase I trial commences for candidate ADHD drug

NicOx enters option agreement for acquisition

Corcept Therapeutics announces launch plan

CSL prepares novel humanized IL-3R-alpha-directed antibodies

MDCO-216 as a new reverse cholesterol transport inducer

New monoamine reuptake inhibitors patented

New ICAM-1-targeted antibodies disclosed by MedImmune

Immunovative Therapies patents novel Th1/killer cells

Ajinomoto set to begin marketing certain Marzulene formulations in Japan

Starpharma launches two pivotal phase III VivaGel studies

Biotest reports promising preclinical data on BT-062

Daiichi Sankyo seeks line extension for denosumab in Japan

Daiichi Sankyo to develop narcotic analgesic for Japanese market

FDA committee issues recommendation for Marqibo

Emergent BioSolutions receives NIAID grant to advance TB vaccine candidate

Scottish university receives grant to investigate spread of leukemia in the blood

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...